Zoekresultaten - Massimino, M.
- Toon 1 - 9 resultaten van 9
-
1
P04.04 FSTL5 EXPRESSION IS A MARKER OF GROUP C METASTATIC MEDULLOBLASTOMAS door Baldi, C., Minasi, S., Gianno, F., Massimino, M., Giangaspero, F., Buttarelli, F.
Gepubliceerd in 2014Text -
2
-
3
-
4
-
5
-
6
-
7
O10.10 RESULTS OF NIMOTUZUMAB AND VINORELBINE, RADIATION AND RE-IRRADIATION FOR DIFFUSE PONTINE GLIOMA IN CHILDHOOD door Massimino, M., Biassoni, V., Miceli, R., Schiavello, E., Warmuth-Metz, M., Modena, P., Giangaspero, F., Spreafico, F., Bach, F., Gandola, L.
Gepubliceerd in 2014Text -
8
P14.77 Reduced dose craniospinal irradiation (CSI) is feasible for standard risk adult medulloblastoma (MBL) patients similarly to pediatric population door Massimino, M, Sunyach, M, Gandola, L, Pecori, E, Spreafico, F, Bonneville Levard, A, Biassoni, V, Schiavello, E, Diletto, B, Stefini, R, Frappaz, D
Gepubliceerd in 2019Text -
9
Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment door Luksch, R, Podda, M, Gandola, L, Polastri, D, Piva, L, Castellani, R, Collini, P, Massimino, M, Cefalo, G, Terenziani, M, Ferrari, A, Casanova, M, Spreafico, F, Meazza, C, Bozzi, F, Marchianò, A, Ravagnani, F, Fossati-Bellani, F
Gepubliceerd in 2005Text